Aa
A
A
Close
1191262 tn?1366766621
Hepatera Completes Enrollment of Phase IIa clinical trial of Myrcludex B
Myrcludex B Preliminary results are expected in June 2014. Read  the following article.

http://www.prnewswire.com/news-releases/maxwell-biotech-venture-funds-portfolio-company-hepatera-completes-enrollment-of-phase-iia-clinical-trial-of-myrcludex-b-for-hbv-248734041.html

Cancel
0 Answers
Page 1 of 1
Your Answer
Avatar universal
Answer
Know how to answer? Tap here to leave your answer...
Answer
Submit Answer
A
A
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis B Community Resources